I’m sceptical also. Fauci talks about data antedolal if not part of a random trial, the FDA wanted a random trial. I posted here if the death rate is say 70%, and they leonlimab saves 7 out of the 10, there is a 1% chance that would have been random. So it is possible to get data not from a random trial and it be fine. Law of large numbers, as N increases, the mean of the experiment will move towards the actual population value, which can be done without a placebo. But the FDA usually wants that 1% p value from a random trial with a bigger N, while we see 2000 per day die... Apparently small minded stats people with no outside the box thinking. Just crazy if you ask me.